Nanoparticles decorated with granulocyte-colony stimulating factor for targeting myeloid cells-Reference-Cited by-同舟云学术

Nanoparticles decorated with granulocyte-colony stimulating factor for targeting myeloid cells

Published:2020 Issue:4 Volume:12 Page:2752-2763
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Margulis Katherine¹²³⁴⁵^ORCID,Honkala Alexander⁶²³⁴,Kalashnikova Irina⁷⁸⁹⁴,Noll Sarah E.¹²³⁴,Hill Meghan⁷⁸⁹⁴,Zare Richard N.¹²³⁴^ORCID,Smith Bryan Ronain⁶²³⁴⁷^ORCID

Affiliation:

1. Department of Chemistry

2. Stanford University

3. Stanford

4. USA

5. The Institute for Drug Research

6. Department of Radiology and the Molecular Imaging Program

7. Department of Biomedical Engineering and the Institute for Quantitative Health Science & Engineering

8. Michigan State University

9. East Lansing

Abstract

Nanoparticles target the protective shield of cancer, which consists of immunosuppressive myeloid cells.

Funder

American Association for Cancer Research

Breast Cancer Research Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2020/NR/C9NR06494J

Reference61 articles.

1. The Terminology Issue for Myeloid-Derived Suppressor Cells

2. Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells

3. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function

4. Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomedicine Targeting Myeloid‐Derived Suppressor Cells Enhances Anti‐Tumor Immunity;Advanced Healthcare Materials;2024-02-11

2. Chemotactic NO/H₂S Nanomotors Realizing Cardiac Targeting of G-CSF against Myocardial Ischemia-Reperfusion Injury;ACS Nano;2023-06-16

3. Nanomedicine as a Novel Strategy to Target Tumor Immune Microenvironment: Current State and Future Perspectives;Handbook of Cancer and Immunology;2022

4. Recent advances in tumor microenvironment-targeted nanomedicine delivery approaches to overcome limitations of immune checkpoint blockade-based immunotherapy;Journal of Controlled Release;2021-04

5. Nanomaterials to target immunity;Advances in Immunopharmacology;2021